Philips stock gets new imaging boost from UniGuide launch

Royal Philips announced on Thursday, October 29, 2026, that it had launched UniGuide 3D Live Guidance in Europe and other CE-marked markets. The new solution brings preprocedural CT-derived planning insights into live procedures conducted on the company's Azurion image-guided therapy platform, according to the Philips press release.

The first release is designed for percutaneous coronary intervention, structural heart procedures and complex vascular interventions. Philips said the system allows physicians to use information from earlier CT examinations while guiding treatment, reducing the need to switch between separate platforms or mentally combine preprocedural and live images.

CT planning enters live procedures

For CT-guided PCI, information from a coronary CT angiography scan can be combined with live image guidance through a three-dimensional overlay or a synchronized side-by-side display. The company said physicians can review vessel characteristics, plaque information and other disease-related findings during the intervention.

UniGuide also supports an open planning ecosystem. Healthcare providers can use planning insights from Philips Advanced Visualization Workspace and compatible third-party solutions inside the Azurion workflow, provided the preprocedural solution meets Philips' DICOM conformance requirements. CT and planning information can be displayed on the FlexVision screen, while physicians can interact with three-dimensional guidance through the tableside Touch Screen Module.

Philips cited a usability study in which 93 percent of participating clinicians said that bringing planning information directly into the procedural workflow could help improve cath lab efficiency and performance. The study included 15 clinicians from the United States and measured questionnaire responses after hands-on experience with Azurion and UniGuide; the findings therefore describe user perceptions rather than demonstrated patient outcomes.

Availability remains geographically limited

Philips said UniGuide 3D Live Guidance has been CE marked and has been available for sale in CE-marked markets since October 23, 2026. The product is currently not available for sale in the United States, limiting its immediate commercial reach despite the company's global healthcare technology footprint.

For Philips, the launch extends the role of Azurion beyond image guidance toward a more integrated workflow linking diagnostic, planning and procedural information. The company said it intends to expand the platform across additional imaging modalities, clinical applications and procedure types. That ambition gives the launch strategic relevance, although the announcement does not provide a financial target or a forecast for sales from UniGuide.

Philips stock traded at 24.41 euros on Lang & Schwarz at 11:11 Berlin time on Friday, October 30, 2026; the real-time quote of Philips stock is available here.

The broader European market backdrop is covered in current market reports.

More news and analyses on Philips stock will follow developments in image-guided therapy and the company's next financial update.